Table 3.
Major Clinical Signs and Laboratory Parameters of the Study Population.
| Normal range | ALA (n = 66) | PLA (n = 27) | P-value | |
|---|---|---|---|---|
| Hepatomegaly | >15 cm | 49 | 12 | 0.007 |
| Total leucocyte count | ||||
| Normal | 4000–11000 | 32 | 14 | 0.76 |
| Elevated | >11,000 | 34 | 13 | |
| Platelet-to–white blood cell ratio | Lower than average | 2 | 13 | <0.0001 |
| Increased ESR | >20 mm | 65 | 27 | 0.63 |
| Hemoglobin | ||||
| Normal | 11–15 | 22 | 16 | 0.02 |
| Decreased | <11 | 44 | 11 | |
| Glycosylated hemoglobin | ||||
| Normal | <5.7 | 43 | 8 | – |
| Pre-diabetic | 5.7–6.4 | 9 | 6 | |
| Diabetic | >6.5 | 14 | 13 | |
| Elevated bilirubin | >0.4 | 43 | 14 | 0.23 |
| Procalcitonin | ||||
| Normal | <0.1 | 4 | 1 | – |
| Bacterial infection unlikely | 0.1–0.25 | 9 | 3 | |
| Bacterial infection possible | 0.25–0.5 | 12 | 1 | |
| Presence of bacterial infection | >0.5 | 11 | 22 | |
| Alkaline phosphatase | ||||
| Normal | 44–147 | 20 | 7 | 0.67 |
| Elevated | >147 | 46 | 20 | |
| SGOT | ||||
| Normal | 5–45 | 26 | 18 | 0.584 |
| Elevated | >45 | 40 | 9 | |
| SGPT | ||||
| Normal | 5–45 | 42 | 18 | 0.781 |
| Elevated | >45 | 24 | 9 | |
| Albumin | ||||
| Normal | 3.8–5.5 | 53 | 5 | <0.0001 |
| Low | <3.7 | 13 | 22 | |
ALA: amoebic liver abscess; PLA: pyogenic liver abscess; SGOT: serum glutamic-oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase; ESR: